"I've spent my professional life working on advancing the treatment of multiple sclerosis and am thrilled to be joining the talented and dedicated team at ...
The study does not involve treatment. The MS Society of Canada describes multiple sclerosis as "... a complex disease. While it is most often diagnosed in ...
... the marketing and distribution contract for the oral drug laquinimod, which is developed for treatment of relapsing-remitting multiple sclerosis (RRMS). ...
...multiple sclerosis (MS) drug Tysabri on February 5, 2010. An advisory sent by the FDA to patients and medical professionals warned that treatment with ...
Biogen IDEC, Inc. (BIIB) – The world's largest producer of medication used in the treatment of multiple sclerosis posted a 48% increase in fourth-quarter ...
Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about the options by talking to a ...
Heuga dedicated his life to research and treatment of multiple sclerosis, his friends said. In 1984, he founded the Jimmie Heuga Center in Edwards, Colo., ...
A new study reveals that multiple sclerosis (MS) patients enrolled in a seven-month disease therapy management (DTM) program show greater adherence to ...
Email this story
